Difficulty: Medium
Average Score: 67%
Practice
Which of the following medications should not be taken by clients who are breastfeeding due to risks like peptic ulcer disease and intracranial bleeds?
Correct answer
D
Rationale
The correct answer is D) Rivaroxaban. Rivaroxaban is a direct oral anticoagulant (DOAC) that can increase the risk of bleeding, including intracranial bleeds. This medication is not recommended for breastfeeding mothers due to the potential harm it can cause to the infant through breast milk.
A) Clopidogrel is an antiplatelet medication that is generally considered safe for use during breastfeeding as it has a low risk of adverse effects to the infant.
B) Enoxaparin is a low molecular weight heparin that is also considered safe for use during breastfeeding as it has minimal excretion into breast milk and is not expected to harm the infant.
C) Dabigatran is another DOAC that, like rivaroxaban, carries a risk of bleeding complications. However, dabigatran is considered safer for use during breastfeeding compared to rivaroxaban.
Educationally, it is important for healthcare providers to have a thorough understanding of medications that are safe for use during breastfeeding to ensure the health and well-being of both the mother and the infant. Knowledge of pharmacology across the lifespan is crucial in providing safe and effective care to patients in various stages of life, including breastfeeding mothers.
A) Clopidogrel is an antiplatelet medication that is generally considered safe for use during breastfeeding as it has a low risk of adverse effects to the infant.
B) Enoxaparin is a low molecular weight heparin that is also considered safe for use during breastfeeding as it has minimal excretion into breast milk and is not expected to harm the infant.
C) Dabigatran is another DOAC that, like rivaroxaban, carries a risk of bleeding complications. However, dabigatran is considered safer for use during breastfeeding compared to rivaroxaban.
Educationally, it is important for healthcare providers to have a thorough understanding of medications that are safe for use during breastfeeding to ensure the health and well-being of both the mother and the infant. Knowledge of pharmacology across the lifespan is crucial in providing safe and effective care to patients in various stages of life, including breastfeeding mothers.